Clinical Trial Update: Evaluation of Atacand® (Candesartan) in Daily Medical Practice

View source ↗

Summary

The document reports the completion of a clinical trial evaluating candesartan (Atacand) for hypertension in daily medical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Atacand (candesartan)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Status: COMPLETED